All NICE products on chronic obstructive pulmonary disease. Includes any guidance, advice and quality standards.
We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Published guidance on this topic (12)
Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.
Published advice on this topic (6)
Set out priority areas for quality improvement in health and social care.
Published quality standards on this topic (1)
Review the evidence across broad health and social care topics.
Reviews the clinical and cost-effectiveness of new treatments.
Review evidence to support adoption of health technologies in the NHS.
Review clinical and cost-effectiveness of specialised treatments.
Assessments of whether procedures are safe enough and work well enough for wider use in the NHS.
Reviews new medical devices for adoption in the NHS.
Review the evidence and likely costs of medical devices and technologies.
Guidance, quality standards and advice being developed.
Guidance and quality standards awaiting development.
Guidance in topic selection.
NICE has today (9 April 2020) published 3 new rapid guidelines on the care of patients with suspected and confirmed COVID-19, and in patients without COVID-19. The guidelines have been designed to maximise the safety of patients whilst enabling services to make the best use of NHS resources.
Examples of how our guidance and standards have been put into practice in the NHS, local authorities, voluntary sector and a range of other organisations.
Showing 3 of 7 shared learning examples for this topic: